quinuclidines has been researched along with rolapitant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aapro, M; Jahn, F; Jordan, K | 1 |
| Rojas, C; Slusher, BS | 1 |
| Hou, F; Le, Q; Li, H; Li, W; Liu, S; Shi, Q; Zheng, L; Zong, S | 1 |
3 review(s) available for quinuclidines and rolapitant
| Article | Year |
|---|---|
Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review.
Topics: Animals; Antiemetics; Antineoplastic Agents; Drug Combinations; Drug Discovery; Guideline Adherence; Humans; Isoquinolines; Nausea; Neurokinin-1 Receptor Antagonists; Practice Guidelines as Topic; Pyridines; Quinuclidines; Serotonin Antagonists; Spiro Compounds; Treatment Outcome; Vomiting | 2015 |
Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron).
Topics: Antiemetics; Antineoplastic Agents; Drug Combinations; Humans; Isoquinolines; Nausea; Neurokinin-1 Receptor Antagonists; Pyridines; Quinuclidines; Spiro Compounds; Vomiting | 2015 |
Prevention of cisplatin-based chemotherapy-induced delayed nausea and vomiting using triple antiemetic regimens: a mixed treatment comparison.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Isoquinolines; Morpholines; Nausea; Neoplasms; Network Meta-Analysis; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Spiro Compounds; Treatment Outcome; Vomiting | 2016 |